ETRACS Alerian MLP Index ETN Series B due July 18, 2042 (NY:AMUB)
Price and Volume
Detailed Quote| Volume | 123,693 |
| Open | 18.65 |
| Bid (Size) | 9.350 (200) |
| Ask (Size) | 28.03 (200) |
| Prev. Close | 18.64 |
| Today's Range | 18.57 - 18.72 |
| 52wk Range | 16.86 - 20.88 |
| Shares Outstanding | 22,000 |
| Dividend Yield | 6.60% |
Top News
More News
UBS declares quarterly coupon payments on Exchange Traded Note: AMUB
November 21, 2023
Performance
Frequently Asked Questions
Is ETRACS Alerian MLP Index ETN Series B due July 18, 2042 publicly traded?
Yes, ETRACS Alerian MLP Index ETN Series B due July 18, 2042 is publicly traded.
What exchange does ETRACS Alerian MLP Index ETN Series B due July 18, 2042 trade on?
ETRACS Alerian MLP Index ETN Series B due July 18, 2042 trades on the New York Stock Exchange
What is the ticker symbol for ETRACS Alerian MLP Index ETN Series B due July 18, 2042?
The ticker symbol for ETRACS Alerian MLP Index ETN Series B due July 18, 2042 is AMUB on the New York Stock Exchange
What is the current price of ETRACS Alerian MLP Index ETN Series B due July 18, 2042?
The current price of ETRACS Alerian MLP Index ETN Series B due July 18, 2042 is 18.72
When was ETRACS Alerian MLP Index ETN Series B due July 18, 2042 last traded?
The last trade of ETRACS Alerian MLP Index ETN Series B due July 18, 2042 was at 11/06/25 04:10 PM ET
What is the market capitalization of ETRACS Alerian MLP Index ETN Series B due July 18, 2042?
The market capitalization of ETRACS Alerian MLP Index ETN Series B due July 18, 2042 is 411.86K
How many shares of ETRACS Alerian MLP Index ETN Series B due July 18, 2042 are outstanding?
ETRACS Alerian MLP Index ETN Series B due July 18, 2042 has 412K shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.